MF59 adjuvant
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MF59 adjuvant, covering 2012-10-30 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59 [Phase 2]